Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Nascimento

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Frontiers in Cell and Developmental Biology|July 24, 2024
Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophyEsther Fernández-Simón, Patricia Piñol-Jurado, Rasya Gokul-Nath, et al.
The Lancet. Neurology|February 21, 2026
Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled studyFrancesco Muntoni, Andres Nascimento, Jinhong Shin, et al.
International Journal of Molecular Sciences|April 13, 2023
Innovative Computerized Dystrophin Quantification Method Based on Spectral Confocal MicroscopyAnna Codina, Mònica Roldán, Daniel Natera-de Benito, et al.
Frontiers in Aging Neuroscience|August 30, 2017
Differences in Adipose Tissue and Lean Mass Distribution in Patients with Collagen VI Related Myopathies Are Associated with Disease Severity and Physical AbilityM A Rodríguez, Luís M Del Rio Barquero, Carlos I Ortez, et al.
Journal of Neuromuscular Diseases|April 11, 2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with NusinersenSelena Trifunov, Daniel Natera-de Benito, Laura Carrera-García, et al.
Annals of Clinical and Translational Neurology|May 30, 2025
Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic SpectrumFlorencia Pérez-Vidarte, Berta Estévez-Arias, Leslie Matalonga, et al.
Journal of Neurology|August 9, 2011
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndromeAmina Chaouch, Juliane S Müller, Velina Guergueltcheva, et al.
Pediatric Neurology|April 24, 2021
Copper Toxicity Associated With an ATP7A-Related Complex PhenotypeDaniel Natera-de Benito, Abel Sola, Paulo Rego Sousa, et al.
Pediatric Neurology|December 17, 2020
The Phenotype and Genotype of Congenital Myopathies Based on a Large Pediatric CohortDaniel Natera-de Benito, Carlos Ortez, Cristina Jou, et al.
Frontiers in Neurology|August 6, 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyThomas O Crawford, John W Day, Darryl C De Vivo, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Frontiers in Cell and Developmental Biology|July 24, 2024
Single cell RNA sequencing of human FAPs reveals different functional stages in Duchenne muscular dystrophyEsther Fernández-Simón, Patricia Piñol-Jurado, Rasya Gokul-Nath, et al.
The Lancet. Neurology|February 21, 2026
Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled studyFrancesco Muntoni, Andres Nascimento, Jinhong Shin, et al.
International Journal of Molecular Sciences|April 13, 2023
Innovative Computerized Dystrophin Quantification Method Based on Spectral Confocal MicroscopyAnna Codina, Mònica Roldán, Daniel Natera-de Benito, et al.
Frontiers in Aging Neuroscience|August 30, 2017
Differences in Adipose Tissue and Lean Mass Distribution in Patients with Collagen VI Related Myopathies Are Associated with Disease Severity and Physical AbilityM A Rodríguez, Luís M Del Rio Barquero, Carlos I Ortez, et al.
Journal of Neuromuscular Diseases|April 11, 2023
Full-Length SMN Transcript in Extracellular Vesicles as Biomarker in Individuals with Spinal Muscular Atrophy Type 2 Treated with NusinersenSelena Trifunov, Daniel Natera-de Benito, Laura Carrera-García, et al.
Annals of Clinical and Translational Neurology|May 30, 2025
Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic SpectrumFlorencia Pérez-Vidarte, Berta Estévez-Arias, Leslie Matalonga, et al.
Journal of Neurology|August 9, 2011
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndromeAmina Chaouch, Juliane S Müller, Velina Guergueltcheva, et al.
Pediatric Neurology|April 24, 2021
Copper Toxicity Associated With an ATP7A-Related Complex PhenotypeDaniel Natera-de Benito, Abel Sola, Paulo Rego Sousa, et al.
Pediatric Neurology|December 17, 2020
The Phenotype and Genotype of Congenital Myopathies Based on a Large Pediatric CohortDaniel Natera-de Benito, Carlos Ortez, Cristina Jou, et al.
Frontiers in Neurology|August 6, 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyThomas O Crawford, John W Day, Darryl C De Vivo, et al.
Pageof 6